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Abstract (250 words) 
The present study tested the hypothesis that concomitant sympathetic and 
parasympathetic stimulation (“autonomic conflict”) may act as a trigger for 
arrhythmia in long QT syndrome (LQTS). Studies were performed in isolated 
innervated rabbit hearts treated with clofilium (100nmol/L); a potassium channel 
blocker. The influence of vagus nerve stimulation (VNS) on spontaneous 
ventricular arrhythmia was assessed in the absence/presence of sustained 
noradrenaline perfusion (100nmol/L) and with sudden adrenergic stress 
(injections of noradrenaline into the perfusion line). Hearts were instrumented 
for a pseudo-electrocardiogram and monophasic action potential recordings. 
VNS, which slows heart rate, was associated with a stimulation frequency-
dependent incidence of spontaneous early afterdepolarisations (EADs) and 
ventricular tachycardia (VT), best predicted by the duration of the 
electrocardiographic T-wave and by triangulation of the ventricular action 
potential. In the presence of sustained (steady-state) noradrenaline perfusion, 
the incidence of EADs and VT with VNS was decreased from 73/55% to 
45/27%, respectively. However, sudden adrenergic stress, imposed during 
periods of sustained VNS, was associated with a transient increase in the 
incidence of severity of observed arrhythmia, as indicated by an increase in the 
average arrhythmia score (1.6±0.4 vs. 2.1±0.7, p=0.01). Analysis of 
electrophysiological parameters suggests that sudden adrenergic stress is 
associated with a transient prolongation, and increased triangulation, of the 
ventricular action potential, which may predispose to triggered activity. This 
study demonstrates that autonomic conflict is pro-arrhythmic stimulus in LQTS. 
However, combined adrenergic and parasympathetic stimulation has a 
complex relationship with arrhythmogenicity, with differences in the effects of 
steady-state adrenergic activation vs. sudden adrenergic stress. 
 
Highlights 
• Long QT syndrome associated arrhythmia were studied with dual 
autonomic stimulation 
• Sudden adrenergic stress increased the severity of arrhythmia 
• Sustained adrenergic stimulation suppressed arrhythmia 
• Changes in electrical parameters mimic profile the temporal profile of 
arrhythmia 
 
Keywords 
autonomic conflict; long QT syndrome; torsades de pointes; sympathetic; 
parasympathetic; autonomic nervous system 
 
Abbreviations 
EAD, early afterdepolarisation; LQTS, long QT syndrome; TdP; torsades de 
pointes; TpTe; T-wave peak-to-end interval; VT, ventricular tachycardia; VNS, 
vagus nerve stimulation.  
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1. Introduction 
Malignant ventricular arrhythmias (e.g. torsades de pointes - TdP) are the 
primary cause of syncope and premature death in patients with abnormal 
prolongation of the electrocardiographic QT interval. Despite extensive 
research, the role of the autonomic nervous system in long QT syndrome 
(LQTS) associated arrhythmogenesis is imperfectly understood. The 
conventional textbook picture of the cardiac autonomic control suggests the two 
branches of the autonomic nervous system exert reciprocal actions on the 
heart, such as in the baroreceptor reflex. In reality, this represents an over-
simplification of a system in which simultaneous and synchronous activation 
often occurs.[1-3] For example, during cold-water immersion, activation of the 
parasympathetically mediated mammalian diving reflex and sympathetic / 
adrenergically driven cold-water shock response occurs simultaneously.[1-3] 
 
Cold-water submersion (head under) is known to be a trigger for 
supraventricular and ventricular arrhythmia in young, seemingly healthy people, 
who do not exhibit evidence of arrhythmia at rest.[3-7] These arrhythmic events 
are not commonly observed in the same individuals during head out cold-water 
immersions (sympathetic stimulation, no parasympathetic stimulations), or 
during facial immersion, with breath-hold, which activates the parasympathetic 
diving reflex and not the cold-shock (sympathetic) response. This suggests that 
simultaneous autonomic activation, as in whole-body cold-water submersion, 
might be an arrhythmogenic stimulus, and is supported by other anecdotal 
observations,[1] but has never been tested experimentally. We recently 
hypothesised that the sudden and simultaneous sympathetic and 
parasympathetic activity, termed “autonomic conflict”, may be a cause of 
arrhythmia associated with cold-water submersion and more generally in 
situations where autonomic co-activation occurs in conjunction with existing 
predisposing factors.[3] 
 
Post-mortem analysis using DNA sequencing has revealed that nearly 30% of 
the victims of seemingly unexplained drowning have cardiac ion channel 
mutations.[8] Moreover, a strong association between swimming and 
arrhythmia/sudden cardiac death has been shown in children with heritable 
LQTS and swimming is recognised as a gene-specific trigger for TdP in patients 
with congenital LQTS type 1.[9-12] Could this represent something more than 
a simple increase in adrenergic tone? Similarly, patients with LQTS type 2 
generally die during times of sudden stress, such as when awoken by an alarm 
clock, suggesting that it is sympathetic activation during periods of high 
parasympathetic tone that triggers TdP.[10, 13] Evidence from 24-hour 
electrocardiogram recordings in patients with acquired LQTS indicates that 
while prevailing rates are relatively slow, there is a significant increase in heart 
rate in the minutes preceding electrical instability and TdP.[14] Therefore, we 
propose that the sequence and timing of autonomic activation plays a critical 
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role in the induction of LQTS associated arrhythmia. In this study, we examined 
the role of autonomic conflict as a trigger for ventricular arrhythmia in conditions 
of acquired (type 2) LQTS. We hypothesised that concomitant sympathetic and 
parasympathetic stimulation would act as a trigger for LQTS associated 
arrhythmogenesis.  
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2. Methods 
2.1 Animal welfare 
All procedures were undertaken in accordance with ethical guidelines set out 
by the UK Animals (Scientific Procedures) Act 1986 and Directive 2010/63/EU 
of the European Parliament on the protection of animals used for scientific 
purposes. Studies conformed the Guide for the Care and Use of Laboratory 
Animals published by the U.S. National Institutes of Health under assurance 
number A5634-01. Studies were approved by local ethics review at King’s 
College London. 
 
2.2 Isolated innervated rabbit heart 
All studies utilised the isolated innervated rabbit heart as described by Ng et al, 
with minor modifications [10]. Experiments were performed in New Zealand 
White Rabbits (2.5-4.5kg). Animals were pre-sedated using a mixture of 
ketamine (Ketaset, 10mg/kg, Fort Dodge, UK), medetomidine hydrochloride 
(Sedator, 0.2mg/kg, Dechra, UK) and butorphanol (Torbugesic, 0.05mg/kg, 
Fort Dodge, UK) (i.m.). Anaesthesia was induced and maintained using 
propofol (5mg as required, Rapinovet, Schering-Plough Animal Health, UK), 
with concomitant heparin (1000 units, Multiparin, UK). Animals were intubated 
and ventilated at 60 breaths per minute of room air. The major blood vessels 
leading to and from the thorax were ligated and cut. Animals were killed by an 
overdose of sodium pentobarbitone solution (160mg/kg i.v.). The descending 
aorta was cannulated and the preparation excised from C1-T12 (on ice). Hearts 
were retrogradely perfused with an oxygenated Krebs-Hensleit buffer, 
containing (in mM): NaCl 114, KCl 4, CaCl 1.8, NaHCO3 24, MgSO4 1, NaH2PO4 
1.1, glucose 11.0 and sodium pyruvate 1.0. Perfusion rate was set to give an 
aortic pressure of 70-80mmHg. The right vagus nerve was isolated from the 
surrounding tissues and placed on silver bipolar stimulating electrodes 
connected to a constant voltage stimulator (DS2A, Digitimer, UK).  
 
2.3 Experimental protocols 
All hearts were instrumented for recording of a pseudo bipolar 
electrocardiogram (low pass=100Hz, high pass=0.3Hz, sampling=1KHz) and 
monophasic action potential from the left ventricular free wall (low pass=100Hz, 
high pass=0.3Hz, sampling=1kHz). Hearts were perfused with clofilium tosylate 
(100nmol/L in DMSO) for 20-minutes prior to the commencement of the 
experimental protocols and throughout the study. 100nmol/L clofilium was 
sufficient to cause substantive QT prolongation without AV-block, which can 
occur with higher concentrations of class III anti-arrhythmic agents.  
 
 
 
2.3.1 Protocol 1 (Sustained noradrenaline) 
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Cardiac responses to VNS were assessed at 2, 5, 10 and 20Hz 
stimulation [pulse width=1ms, amplitude=10V, duration=2 minutes per 
frequency] in the absence and presence of 100nmol/L noradrenaline 
(+50µM ascorbate). This represents a submaximal concentration in the 
rabbit heart and produces a marked and sustained chronotropic and 
electrophysiological action. Noradrenaline was perfused for a minimum 
of 10-minutes prior to nerve stimulation.  
 
2.3.1 Protocol 2 (Bolus noradrenaline) 
Noradrenaline (0.1ml of 1mM stock) was injected directly into the bubble 
trap of the perfusion apparatus at intrinsic heart rates and following 2-
minutes of VNS at 5 and 10Hz. Hearts were allowed to recover for 10-
minutes between injections. 
 
2.4 Blinding and randomisation 
To reduced inter-operator variability, studies were conducted and analysed by 
a single experimenter. The sequence of experimental protocols and order of 
stimulations in Protocols 1 and 2 were randomised prior to the study. The nature 
of the paired study design prevented blinding of the experimenter to the study 
protocols. 
 
2.5 Data analysis 
Experiments were ranked per the severity of observed arrhythmia, using a 
predefined arrhythmia score (no arrhythmia=1, early afterdepolarisations 
(EADs)=2, ventricular tachycardia (VT)=3, sustained VT (>20secs) or 
ventricular fibrillation=4). Note that this is a simple hierarchical scoring system, 
in which the absolute score at each level is not a true quantification of 
arrhythmia severity. Curtis and Walker have previously shown the validity of 
such hierarchical systems for use in arrhythmia quantification.[15] EADs were 
assessed first in monophasic action potential recordings and then confirmed in 
ECG recordings - evidenced by an R-T ectopics in the latter and premature 
beat occurring before repolarisation of the preceding action potential in MAP 
recordings. Because TdP can present monomorphic or polymorphic patterns in 
ECG recordings from the same subject, depending on the relative angle of the 
recording electrode, data are presented in terms of the number of episodes of 
VT. In most cases, ECG and monophasic action potential parameters were 
assessed from 10-beat averages of normally conducted beats. Monophasic 
action potential duration was assessed at 90% repolarisation (MAPD90). Action 
potential triangulation was calculated as MAPD90-MAPD30. 
 
 
 
2.6 Statistics 
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Arrhythmia scores were compared by Wilcoxon’s matched-groups signed rank-
sum tests. For electrophysiological parameters, parametric statistical analyses 
were applied on the basis that the distribution of the QT interval is Gaussian 
and on the assumption that other electrogram parameters and related 
measures (e.g. action potential triangulation) are similarly distributed.  
Statistical comparisons were made using paired Student’s t-tests and repeated 
measures one or two-way ANOVA with Sidak’s post-hoc tests, as appropriate. 
p<0.05 was considered significant. Continuous variables are presented as 
means (standard deviation (SD)).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Results 
 8 
3.1 VNS is a trigger for EADs and VT in LQTS 
 
The representative trace in Figure 1A demonstrates a frequency-dependent 
slowing of heart rate with VNS in a clofilium-treated rabbit heart. In this 
example, spontaneous EADs were observed during high-intensity VNS (20Hz). 
Data presented on the left of Figure 1B&C summarise the incidence of 
arrhythmia with VNS in 11 experiments, and show that VNS acted as a 
stimulation frequency-dependent trigger for spontaneous EADs and VT in 
LQTS; with no arrhythmia observed in baseline conditions (i.e. in hearts beating 
at their intrinsic rate). The percentage of hearts exhibiting EADs increased from 
0% at baseline to 73% with 20Hz VNS, and the maximum incidence of 
spontaneous VT was 55%. Neither EADs or spontaneous VT were observed 
with VNS before clofilium perfusion (data not shown). Arrhythmia were 
suppressed by the restoration of normal beating rates, either spontaneously or 
by short-term ventricular pacing (after which hearts returned to sinus rhythm). 
 
3.2 T-wave duration and action potential triangulation predict EADs during 
VNS 
 
Table 1 presents a comparison of electrophysiological parameters in hearts 
with and without spontaneous EADs during VNS (5Hz) and shows that the 
duration of the T-wave (TpTe interval), a measure of ventricular dispersion of 
repolarisation, and triangulation of the ventricular action potential are the best 
predictors of VNS-associated triggered activity.  
 
3.3 Sustained noradrenaline perfusion supresses long QT associated 
arrhythmia 
In the presence of sustained (steady-state) noradrenaline the propensity for 
EADs and VT with VNS was substantially reduced (Figure 1B&C). With VNS at 
20Hz, 73% of hearts exhibited EADs in control conditions, compared to only 
45% in the presence of noradrenaline. TdP exhibited a similar pattern, with an 
incidence of 55% in control conditions vs. 27% during noradrenaline perfusion. 
The average arrhythmia score, a measure of the severity of observed 
arrhythmia, was reduced by sustained noradrenaline perfusion (Figure 1D&E). 
 
3.4 VNS antagonises the action of catecholamines on heart rate but not on 
ventricular electrophysiology 
 
The electrophysiological consequences of sustained (steady-state) 
noradrenaline perfusion are presented in Figure 2. As expected, noradrenaline 
perfusion resulted in an increase in heart rate and shortening of the QT interval, 
as well as a reduction in the magnitude of action potential triangulation. In the 
presence of noradrenaline, VNS slowed heart rate to a greater degree than that 
observed in control conditions. At baseline, and with low intensity VNS (2Hz), 
heart rate was elevated by noradrenaline, but this effect was lost with at higher 
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intensities of stimulation (Figure 2B) - showing that the vagus nerve 
antagonises the action of noradrenaline on heart rate. By comparison, 
adrenergic-dependent shortening of the QT interval was not reversed by VNS 
(Figure 2C). In fact, the magnitude of VNS-dependent QT prolongation was less 
in the presence of catecholamines (68 (5)ms vs. 127 (14)ms, p=0.003) and so 
QT interval was substantially shorter at all frequencies of nerve stimulation, 
despite a similar underlying heart rate during high intensity VNS (see Figure 
2C). Similarly, a greater increase in ventricular dispersion of repolarisation (as 
indicated by prolongation of the TpTe interval) and triangulation of the action 
potential was observed with VNS in the absence of adrenergic stimulation 
(Figure 2D&E). The TpTe interval increased by 136 (34)% with VNS alone and 
64 (22)% with VNS and noradrenaline perfusion (p=0.004). Action potential 
triangulation increased by 70±16ms with VNS in control conditions vs. 28±9ms 
with VNS in the presence noradrenaline (p=0.003). Taken together, this 
suggests that VNS does not antagonise the electrophysiological action of 
exogenous noradrenaline in the rabbit ventricle, whilst accentuated antagonism 
is evident in changes in heart rate. This likely reflects the greater influence of 
the parasympathetic nervous system on the sinoatrial node. The anti-
arrhythmic action of sustained noradrenaline perfusion in LQTS may be 
attributed to the relative shorter ventricular action potential and reduced action 
potential triangulation during combined autonomic stimulation. 
 
3.5 Bolus noradrenaline facilitates and exacerbates arrhythmia associated 
with QT prolongation 
 
Electrical pickup on the ECG recordings during direct sympathetic nerve 
stimulation prevents accurate assessment of arrhythmia in the isolated 
innervated rabbit heart. However, noradrenaline injections appear to be a good 
correlate of sympathetic nerve stimulation. Figure 3 shows the heart rate 
response to bolus noradrenaline compared with moderate intensity sympathetic 
nerve stimulation (10Hz, 40V, 2ms pulse duration) in the isolated rabbit heart. 
The presented data show that the initial heart rate response to noradrenaline is 
marginally slower than that of direct nerve stimulation (owing to perfusion 
delay), however, the maximum heart rate and time to peak heart rate response 
was similar between conditions.  
 
Data from 12 experiments on the influence of sudden adrenergic stress on the 
incidence of LQTS associated arrhythmia are presented in Figure 4.  Injection 
of a bolus of noradrenaline into the perfusion line acted in a bi-phasic manner- 
first increasing the risk of arrhythmia in the 10 to 20 second period immediately 
after injection and then acting to accelerate the underlying heart rate, 
suppressing arrhythmic events. In stage 1, bolus noradrenaline acted to 
increase the severity of the observed arrhythmia, with a dependence on the 
underlying conditions. For instance, noradrenaline commonly triggered EADs 
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in the absence of pre-existing arrhythmia or caused VT in hearts already 
exhibiting ectopic activity. As such, VT was more commonly observed with 
noradrenaline perfusion during high intensities of VNS. In two of twelve hearts, 
bolus noradrenaline led to periods of sustained VT (>20secs), which in one 
case degenerated into ventricular fibrillation. The incidence of spontaneous 
EADs, VT and sustained VT/VF with VNS and VNS plus bolus noradrenaline 
are presented in Figure 4B-D. 67% of hearts exhibited spontaneous VT with 
VNS + bolus noradrenaline vs. 33% with VNS alone. Spontaneous EADs were 
observed in just 1 heart following noradrenaline perfusion in the absence of 
VNS. The severity of arrhythmic events was increased by combined 
stimulation, over VNS alone, as evidenced by an increase in the average 
arrhythmia score (Figure 4E&F).  
 
3.6 Bolus noradrenaline causes a transient increase in action potential 
duration and triangulation 
 
To investigate the impact of sudden adrenergic stress on ventricular 
electrophysiology in LQTS we analysed changes in electrophysiological 
parameters following the injection of a bolus of noradrenaline in baseline 
conditions (i.e. in the absence of VNS). This was necessitated by the high 
incidence of arrhythmia during combined autonomic stimulation. These data 
are presented in Figure 4. Bolus noradrenaline caused a rapid increase in heart 
rate that recovered to baseline over a 10-minute period (Figure 5A). A transient 
increase in the duration of the QT interval, ventricular MAPD90 and magnitude 
of action potential triangulation was observed within approximately 10-seconds 
of noradrenaline injection; followed by a sustained shortening of ventricular 
repolarisation and reduction of action potential triangulation (Figure 5B-D). This 
suggests that application of sudden adrenergic stress in LQTS leads to 
transient pro-arrhythmogenic alterations in ventricular electrophysiology. 
Indeed, the time course of changes in ventricular repolarisation paralleled the 
increase in the risk of arrhythmic events immediately following noradrenaline 
perfusion (during VNS), as well as the suppression of said arrhythmia with 
sustained adrenergic activation. Dispersion of repolarisation, as assessed from 
the duration of the TpTe interval, was similar at all time points (Figure 5E). No 
difference in beat-to-beat variability for QT interval or APD was observed at any 
time point (data not shown). 
 
 
 
4. Discussion 
To our knowledge, this is the first study to show the importance of dynamic 
interplay between the two branches of the autonomic nervous system in LQTS-
associated arrhythmogenesis. Our results show that sudden adrenergic stress 
superimposed on a background of sustained parasympathetic activation is pro-
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arrhythmic. However, combined adrenergic and parasympathetic stimulation 
has a complex relationship with arrhythmogenicity in LQTS. Whilst sustained 
(steady-state) noradrenaline perfusion suppresses the pro-arrhythmic action of 
VNS, application of a sudden adrenergic stressor acts to increase the severity 
of observed events. Noradrenaline rarely triggers spontaneous VT (1/12 hearts) 
in the absence of VNS, suggesting that concomitant autonomic activation (or 
“autonomic conflict”) is required for the adrenergic facilitation of LQTS-
associated arrhythmia. Importantly, this observation parallels the clinical profile 
for patients with congenital LQTS type 2, who commonly die when awoken 
suddenly by an alarm clock - suggesting that they experience lethal arrhythmia 
when a surge in sympathetic / adrenergic activity is superimposed during a time 
of high parasympathetic tone (i.e. during rest or sleep). [10, 13] By 
recapitulating LQTS type II, using drugs that block IKr, we show that the number 
and severity of arrhythmia observed with VNS alone is exacerbated by 
application of adrenergic stressor during sustained parasympathetic 
stimulation. Thus, the facilitation of arrhythmogenesis in LQTS by adrenergic 
stress is critically dependent upon the timing and sequence of autonomic 
stimulation. This critical dependence on the sequence of events likely 
contributes to the stochastic nature of arrhythmia and the difficulties in 
predicting any individual’s risk of sudden death or the timing of that death.  
 
The majority of studies on the influence on adrenergic activation on cardiac 
electrophysiology have focussed on steady-state responses and there has 
been only limited investigation into the importance of dynamic changes in 
autonomic tone in LQTS. In studies in the isolated ventricular wedge 
preparation, Schimizu et al. reported that in LQTS type 2, noradrenaline 
perfusion leads to a transient increase in transmural dispersion of 
repolarisation.[16] The authors showed that increased repolarisation 
heterogeneity correlated with an increase in the susceptibility to spontaneous 
and electrically induced VT. In our analysis of T-wave duration we found no 
evidence that adrenergic stress results in an increase in dispersion of 
repolarisation in the rabbit ventricles, but observed a transient increase in 
action potential duration and triangulation. The rate of repolarisation is thought 
to be an important factor in the generation of EADs, as this may lead to the 
reactivation of the inward calcium current and the reversal of membrane 
potential - either directly via inward current through the L-type calcium channels 
or due to stimulated release of calcium from the sarcoplasmic reticulum.[17-19] 
Thus, the increase in action potential triangulation with sudden adrenergic 
stress combined with parasympathetic activation may facilitate EADs and 
explain the transient increase in risk of arrhythmia with concomitant autonomic 
stimulation. Notably, recurrent ectopic activity is one mechanism thought to 
underpin TdP and is a feasible mechanism for the increased incidence of VT 
observed during bolus noradrenaline injections.[20] Our observations parallel a 
report by Liu et al., who demonstrated a transient risk for EADs in isolated 
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myocytes from rabbits with congenital LQTS type 2 on exposure to isoprenaline 
- attributed to differential kinetics for activation of the L-type calcium current and 
slow component of the delayed rectifying potassium current.[21] A similar 
kinetic mismatch in the targets for protein kinase A dependent phosphorylation 
was predicted by integrated computational modelling of calcium and beta-
adrenergic signalling.[22] Interestingly, in a follow up study, Xie et al. predicted 
that that sudden adrenergic stress favours the transition from VT to VF, due to 
dynamic changes in APD restitution, which may have relevance to our 
observation that bolus noradrenaline is associated with a transient risk of more 
severe tachyarrhythmia.[23] Faster onset kinetics of the L-type calcium current 
may explain the transient increase in action potential duration, triangulation and 
incidence of VT with bolus noradrenaline perfusion in our study. With more 
sustained adrenergic stimulation, the current carried by IKs is increased, acting 
to shorten the action potential and to reduce the risk of further ectopic activity. 
The same mechanism could explain why sustained adrenergic stimulation acts 
to suppress arrhythmia. Indeed, loss-of-function mutations in the pore-forming 
subunits of channels that conduct IKs are the most common form of congenital 
LQTS. In this scenario, IKs is weaker and does not counteract the increase in L-
type current during adrenergic-stimulation, promoting EADs. Another factor in 
the suppression of LQTS-associated arrhythmia by sustained adrenergic 
stimulation is the resulting acceleration of heart rate, which shortens the action 
potential, secondary to changes in the concentration of intracellular ions, 
including, Na and Ca. Bradycardia is a well-established trigger for drug-induced 
LQTS-related arrhythmia and tachypacing can prevent sudden death both 
acutely and as a long-term therapy.[24, 25] 
 
That VNS is an independent trigger for arrhythmia in drug-induced LQTS is not 
surprising and is in keeping with existing clinical and experimental evidence. 
Bradycardia is a well-established risk factor for TdP and Farkas et al. previously 
demonstrated that the induction of TdP in the phenylephrine-sensitised rabbit 
is dependent upon activation of the parasympathetic nervous system.[26] 
Phenylephrine, a selective alpha1-adrenoceptor agonist, increases blood 
pressure and activates the baroreceptor reflex, leading to a slowing of heart 
rate via the vagus nerve. In our study, VNS causes prolongation and 
triangulation of the ventricular action potential, which likely explains the pro-
arrhythmogenic action of parasympathetic activation in LQTS. It is notable that 
one of the best correlates of ectopic activity following VNS was the TpTe 
interval, a measure of dispersion of repolarisation. This observation could 
indicate the requirement for a critical gradient of repolarisation in order that 
ectopic beats can propagate through the ventricular myocardium. Alternatively, 
the TpTe interval may simply reflect the development of islands of tissue with 
prolonged APD from where ectopic activity first arises.[27] Furthermore, 
increased dispersion of repolarisation is a substrate that favours re-entrant 
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arrhythmia and may predispose to TdP, in keeping with our previous 
observations.[28] 
 
Beta-adrenoceptor antagonists are the first line therapy for congenital LQTS, 
with an efficacy that is determined by the molecular basis of QT-prolongation. 
Beta-adrenoceptor blockade is reported to be most effective in LQTS type 1 
and only moderately effective in LQTS type 2 and LQTS type 3.[10] On this 
basis, we propose that the partial effectiveness of beta-blockade in congenital 
LQTS type 2 reflects that arrhythmia can be triggered by parasympathetic 
activation alone, but that the incidence and severity of arrhythmia is increased 
by sudden adrenergic stress. Beta-blockade likely inhibits the latter case, but 
clearly this does not entirely abolish the risk of TdP in this patient population. 
Many useful therapeutic drugs, including antipsychotics and antiarrhythmics, 
also cause QT prolongation and carry risk of TdP and sudden cardiac death 
[29]. Where the risk-to-benefit ratio is high, QT-prolonging drugs should be 
withdrawn in patients exhibiting excessive QT prolongation or symptoms of 
LQTS (e.g. dizziness, syncope). However, when the risk to benefit ratio is low 
(i.e. low-risk, high-benefit), our data suggest that patients could benefit from 
prophylactic beta-adrenoceptor blockade. That is to say, beta-blockade may be 
an effective strategy to mitigate risk of sudden death in drug-induced LQTS, in 
addition to congenital forms, and where there is no alternative to use of QT-
prolonging drugs. Symptoms of syncope and the risk of sudden death in 
patients with congenital LQTS who are refractory to beta-blockade can also be 
mitigated by left sympathetic denervation, a surgical procedure that involves 
ablation of left stellate ganglion; the major source of sympathetic efferent nerve 
fibres that innervate the ventricles. Schwartz et al. have previously shown the 
efficacy of this approach in patients with congenital LQTS who continue with 
symptoms of syncope or cardiac arrest despite beta-blocker therapy.[30] With 
type 2 LQTS, where bradycardia is an independent trigger for arrhythmia, 
further benefits could be provided by the combined use of beta-
blockers/denervation and chronic atrial pacing.[25] 
 
We have previously suggested that autonomic conflict, the simultaneous 
activation of the sympathetic and parasympathetic inputs to the heart, might be 
an arrhythmogenic trigger.[3] The basis for this is observations of substantive 
cardiac dysrhythmia and arrhythmia in young healthy adults within the first 
minute of submersion in cold-water; a potent stimulator of the sympathetically 
driven cold-water shock response and parasympathetcally mediated 
mammalian diving reflex. Importantly, similar events are not commonly 
observed in the same participants during head out cold-water immersion, or 
with facial immersion alone, suggesting that autonomic co-activation plays a 
critical role. We recently reported that combined autonomic stimulation (i.e. 
sustained noradrenaline + VNS) is insufficient to cause significant arrhythmia 
in healthy isolated rabbit hearts.[31] However, we show presently that 
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concomitant stimulation can trigger severe arrhythmia in the presence of a 
predisposing electrophysiological abnormality, and in a manner, that is critically 
dependent on the timing of the adrenergic stimulus. Autonomic conflict may 
also have broader importance in other forms of LQTS, for example, it may 
explain why swimming is a gene-specific trigger for TdP and sudden death in 
congenital LQTS type 1.[9] Moreover, dynamic events, leading to sudden 
alterations in autonomic tone, are likely to be an important contributing factor in 
many arrhythmogenic syndromes and pre-disposing conditions. For example, 
swimming may be a trigger for arrhythmia in patients with genetic mutations 
associated with catecholinergic polymorphic ventricular tachycardia.[11] 
Greater understanding of how the dynamic changes in autonomic tone 
influence electrophysiology and arrhythmogensis in disease may be an 
important factor in the development of more effective therapeutic strategies for 
the management of sudden cardiac death. 
 
Animal models of TdP are essential for studies of the arrhythmogenic 
processes in LQTS, and also have utility for safety screening of QT prolonging 
drugs, however, there are several limitations with existing experimental 
approaches. These include: the necessary use of anaesthetic agents in in vivo 
models,[26] a failure to predict the pro-arrhythmic potential of recognised 
torsadegenic drugs,[26] use of non-physiological conditions (e.g. perfusion of 
acetylcholine to mimic VNS), a reliance on expensive protocols (e.g. chronic 
atrioventricular block in the dog),[32] and the low incidence of TdP in the 
absence of electrical induction protocols.[16] In this study, we describe a novel 
protocol that recapitulates LQTS-associated arrhythmogenesis, including 
spontaneous EADs and VT. With concomitant autonomic stimulation (VNS + 
bolus noradrenaline) the maximum incidence of EADs and VT in our study was 
92% and 67%, respectively. As such, the innervated rabbit heart may be a 
useful model for the study of LQTS-associated arrhythmia. This approach has 
several potential advantages over existing models, including; the preservation 
of natural cardiac activation and repolarisation patterns, the ability to perform 
repeat measurements in the same heart, no requirement for anaesthetic 
agents, that heart rate can be altered physiologically by direct nerve stimulation 
and great flexibility / adaptability (e.g. rapid washout of drugs, altered ionic 
composition). Moreover, the model is relatively low-cost and requires only 
minimal training to implement. This facility of the ex vivo innervated heart in 
drug safety screening will require extensive validation and is a focus for future 
work.  
4.1 Limitations 
There are several limitations that deserve discussion. Firstly, in preliminary 
experiments we found that direct sympathetic nerve stimulation caused 
significant electrical pickup on ECG recordings, making it difficult to accurately 
determine the onset and type of arrhythmia. For this reason, we used 
exogenous noradrenaline, which may not be directly akin to nerve stimulation, 
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where the “fright” response is likely mediated by local neurotransmitter release. 
Secondly, both ketamine and medetomidine can influence autonomic control. 
However, as experiments were performed in an in vitro preparation, with 
significant time for drug washout, we believe this is unlikely to influence our 
results, and nerve responses were robust and reproducible throughout the 
experimental protocols. Thirdly, the incidence of VT at baseline between 
protocols 1 and 2 was modestly different (2 vs. 4 episodes), which could simply 
reflect that more extended periods of VNS (as in protocol 1) are associated with 
a higher incidence of spontaneous arrhythmia. However, given that difference 
between the groups is not statistically significant, this observation may simply 
be down to chance. Fourthly, on the slowing of heart rate with VNS, it was 
common for map recordings to exhibit unstable diastolic potentials (when 
previously stable at baseline), which was likely attributed to slight movement of 
the recording electrode secondary to altered contractile motion of the heart. 
This can be seen in the example trace shown in Figure 1A. To avoid mechanical 
triggering of arrhythmia, we opted not to re-orientate the electrode mid protocol. 
However, despite the observed instability, it was still possible to accurately 
detect the onset of EADs, particularly as our analysis relied on concomitant 
observations in MAP recordings and in the ECG. Finally, clofilium is an K 
channel blocker with a similar IC50 to E4031 and dofetilide, and has proven 
efficacy for the induction of TdP in rabbits.(ref) The purpose of the present study 
was to develop a model that replicates congenital LQTS and not necessarily to 
compare directly to clinically used (or historical) pharmaceutical agents (e.g. d-
sotalol, dofetilide). Whilst alternative class III agents are more commonly 
employed in experimental studies, many K channel blockers exhibit similar 
potency and we do not believe that our use of clofilium detracts from the 
conclusions of the present study.[33] Moreover, we have previously shown that 
VNS can trigger TdP in rabbit hearts treated with E4031, a result replicated with 
clofilium.[28]   
 
5. Conclusions 
Autonomic conflict, the simultaneous activation of parasympathetic and 
sympathetic autonomic inputs to the heart, can facilitate arrhythmogenesis in 
LQTS. Dynamic alterations in autonomic tone may be an important contributory 
factor in many arrhythmogenic syndromes or in conditions that predispose to 
ventricular arrhythmia. 
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Figure 1. Sustained noradrenaline perfusion suppresses LQTS associated arrhythmia. A) Representative traces demonstrating 
the slowing of heart rate with increasing intensities of vagus nerve stimulation (VNS) in a clofilium-treated (100nmol/L) rabbit heart. 
In this example, early afterdepolarisations (EADs) are triggered at 20Hz VNS. B&C) Arrhythmia counts for 11-experiments 
demonstrating a reduction in the incidence of EADs and ventricular tachycardia (VT) with sustained noradrenaline (NA, 100nmol/L) 
perfusion. D&E) Individual and average (Tukey’s box plot) arrhythmia scores during VNS and with VNS+NA (sustained). Different 
from VNS alone; *p<0.05. Comparisons by Wilcoxon’s matched-groups signed rank-sum test (n=11). 
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Figure 2. Electrophysiological changes during VNS with and without 
sustained noradrenaline. A) Representative traces demonstrating changes in 
electrocardiogram (ECG) parameters during VNS in a clofilium-treated 
(100nmol/L) rabbit heart, with and without sustained noradrenaline (NA, 
100nmol/L) perfusion. B-E) Average data on the change in heart rate, QT 
interval, T-wave peak to end interval (TpTe) and monophasic action potential 
(MAP) triangulation. Data represent means (SD). Different from clofilium 
(control); *p<0.05. Two-way repeated measures ANOVA, with Sidak’s post-hoc 
tests (n=7).  
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Figure 3. Comparison of heart rate response to sympathetic nerve 
stimulation and bolus noradrenaline injection. A) Temporal profile of the 
change in heart rate with bilateral electrical stimulation of the cardiac 
sympathetic efferent nerves (10Hz, 2ms pulse width, 40V) and with injection of 
0.1ml of 1mM noradrenaline stock solution into the perfusion line.  B&C) Mean 
data on the time to peak heart rate responses and the change in heart rate with 
sympathetic nerve stimulation (SNS) and noradrenaline bolus injection.  
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Figure 4. Bolus noradrenaline facilitates LQTS associated arrhythmia. A) Representative episodes of spontaneous ventricular 
tachycardia (VT) in a clofilium-treated (100nmol/L) rabbit heart. The left trace was observed during VNS and the right following bolus 
noradrenaline (NA) perfusion (0.1ml of 1mM stock), in separate experiments. B-D) Arrhythmia counts for 12-experiments, 
demonstrating an increase in the incidence of early aftedepolarizations (EADs), VT and sustained VT (VTsus)/ventricular fibrillation 
(VF) with VNS + NA (bolus). E&F) Individual and average arrhythmia scores during VNS and with VNS+NA (bolus). Different from 
VNS alone; *p<0.05. Comparisons by Wilcoxon’s matched-groups signed rank-sum test (n=12). 
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Figure 5. Electrophysiological effects of bolus noradrenaline in LQTS. A) 
Experimental trace demonstrating the change in heart rate and monophasic 
action potential duration (MAPD90) following bolus noradrenaline (NA) 
perfusion (0.1ml of 1mM stock) in a clofilium treated (100nmol/L) rabbit heart. 
A transient increase in MAPD90 is seen immediately following NA perfusion. 
Inset are representative action potential recordings from the timepoints noted 
by []. B-E) Average data of QT interval, T-wave peak to end interval (TpTe), 
MAPD90 and action potential triangulation at baseline, at peak response and at 
30-seconds post-peak response. Data represent means(SD). Different from 
baseline; *p<0.05. Comparisons by one-way ANOVA, with Sidak’s post-hoc 
tests (n=9). 
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Table 1. Electrophysiological predictors of early afterdepolarisations. 
 
 
Comparison of electrocardiogram and monophasic action potential parameters in hearts with and without early afterdepolarisations 
(EADs) during vagus nerve stimulation (VNS) at 5Hz. 10-beat averages immediately before the first EAD or the last 10-beats before 
the cessation of VNS. BBV=beat-to-beat variability. Data represent means (SD). Comparisons by paired Student’s t-tests. *p<0.05, 
 (n=6 per group). 
 
 
 
 
 
 
 
 
Parameters Experiments without EADs Experiments with EADs P value 
RR interval (ms) 465 (98) 560 (105) 0.139 
QT Interval (ms) 335 (38) 382 (50) 0.098 
TpTe Interval (ms) 59 (10) 99 (21) *0.001 
APD90 (ms) 261 (26) 285 (42) 0.176 
APD BBV (ms) 2.8 (3.9) 12.3 (24.0) 0.364 
Action potential triangulation (ms) 125 (17) 164 (39) *0.045 
